Valion Bio (VBIO) Cash & Equivalents (2020 - 2026)
Valion Bio (VBIO) recorded Cash & Equivalents of $2.11 million in Q2 2026, up 78.0% from $1.18 million a year earlier.
Powered by 
Analysis
Valion Bio (VBIO) Cash & Equivalents (2020 - 2026) Analysis & Trends
At the end of FY2025, Valion Bio reported Cash & Equivalents of $12.65 million, up 531.6% from FY2024.
- Annual Cash & Equivalents has a four-year compound annual growth rate of -0.6% (FY2021 to FY2025).
- Across earlier years, Cash & Equivalents came in at $2 million in FY2024 (-41.0%), $3.4 million in FY2023 (-3.5%), $3.52 million in FY2022 (-72.9%) and $12.98 million in FY2021.
- Quarterly Cash & Equivalents has ranged from $700,000 in Q1 2025 to $12.98 million in Q4 2021 over the past five years.
- On a year-over-year basis, Cash & Equivalents rose in three of the last seven quarters, with growth averaging 63.3%.
- Peak year-over-year performance for Cash & Equivalents in the last five years was growth of 531.6% in Q4 2025, against a decline of 72.9% in Q4 2022 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 9.55 Bn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | 400.00 Mn |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 1.82 Bn |
| 10 | Valion Bio | 73,008.00 | -25.39 Mn | - | 2.11 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.11 Mn |
| Mar 31, 2026 | 7.22 Mn |
| Dec 31, 2025 | 12.65 Mn |
| Sep 30, 2025 | 3.50 Mn |
| Jun 30, 2025 | 1.18 Mn |
| Mar 31, 2025 | 669,000.00 |
| Dec 31, 2024 | 2.00 Mn |
| Sep 30, 2024 | 2.20 Mn |
| Jun 30, 2024 | 3.70 Mn |
| Mar 31, 2024 | 1.70 Mn |
| Dec 31, 2023 | 3.40 Mn |
| Sep 30, 2023 | 5.20 Mn |
| Jun 30, 2023 | 2.70 Mn |
| Mar 31, 2023 | 5.20 Mn |
| Dec 31, 2022 | 3.52 Mn |
| Sep 30, 2022 | 6.33 Mn |
| Jun 30, 2022 | 9.05 Mn |
| Mar 31, 2022 | 10.80 Mn |
| Dec 31, 2021 | 12.98 Mn |
| Dec 31, 2020 | 1.04 Mn |
API Access
Valion Bio Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=VBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "VBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=VBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();